Currency In USD
| Previous Close | 3.51 |
| Open | 3.4 |
| Day High | 3.65 |
| Day Low | 3.31 |
| 52-Week High | 4.35 |
| 52-Week Low | 1.63 |
| Volume | 56,192.23 |
| Average Volume | 2.35M |
| Market Cap | 7.83M |
| PE | -0.92 |
| EPS | -3.94 |
| Moving Average 50 Days | 2.64 |
| Moving Average 200 Days | 2.54 |
| Change | 0.12 |
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
GlobeNewswire Inc.
Feb 05, 2026 1:30 PM GMT
Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing electrocardiography (“ECG” or “EKG”) through the integrati
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
GlobeNewswire Inc.
Jan 29, 2026 1:30 PM GMT
Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire Inc.
Dec 15, 2025 9:15 PM GMT
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integra